Disease modelling

Organoid
#Disease modelling #National Institutes of Health (NIH) #New approach methodologies (NAMs) #Organoids

First-of-its-kind organoid centre to reduce reliance on animal models

A new US Standardized Organoid Modeling (SOM) Center will be dedicated to using cutting-edge technologies to develop standardised organoid-based new approach methodologies (NAMs).   With contracts totalling $87 million for the first three years, the centre will be housed at the Frederick National Laboratory for Cancer Research (FNLCR),… Read More

#News

#Assays #bit bio #Disease modelling #Drug discovery #iPSC #iPSC-derived cells

Listicle: Get the best out of human iPSC derived cells in your assays

Watch this DDW listicle, 5 ways to get the best out of human iPSC-derived cells in your assays from bit.bio, for free now. Transitioning to human iPSC-derived cells can open powerful opportunities for drug discovery, neuroscience, and disease modelling, but success depends on how you handle and culture them. Read More

#News